GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Pharmaceutical Corp (XKRX:185750) » Definitions » Cyclically Adjusted Book per Share

Chong Kun Dang Pharmaceutical (XKRX:185750) Cyclically Adjusted Book per Share : ₩41,045.60 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Chong Kun Dang Pharmaceutical Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Chong Kun Dang Pharmaceutical's adjusted book value per share for the three months ended in Mar. 2024 was ₩64,778.533. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩41,045.60 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-09), Chong Kun Dang Pharmaceutical's current stock price is ₩106700.00. Chong Kun Dang Pharmaceutical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₩41,045.60. Chong Kun Dang Pharmaceutical's Cyclically Adjusted PB Ratio of today is 2.60.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Chong Kun Dang Pharmaceutical was 3.13. The lowest was 2.42. And the median was 2.66.


Chong Kun Dang Pharmaceutical Cyclically Adjusted Book per Share Historical Data

The historical data trend for Chong Kun Dang Pharmaceutical's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Pharmaceutical Cyclically Adjusted Book per Share Chart

Chong Kun Dang Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 40,048.30

Chong Kun Dang Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 40,048.30 41,045.60

Competitive Comparison of Chong Kun Dang Pharmaceutical's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Chong Kun Dang Pharmaceutical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chong Kun Dang Pharmaceutical's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chong Kun Dang Pharmaceutical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Chong Kun Dang Pharmaceutical's Cyclically Adjusted PB Ratio falls into.



Chong Kun Dang Pharmaceutical Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chong Kun Dang Pharmaceutical's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=64778.533/118.8477*118.8477
=64,778.533

Current CPI (Mar. 2024) = 118.8477.

Chong Kun Dang Pharmaceutical Quarterly Data

Book Value per Share CPI Adj_Book
201406 24,051.496 99.353 28,770.797
201409 24,469.315 99.608 29,195.665
201412 25,048.949 99.098 30,041.070
201503 25,013.355 99.720 29,811.269
201506 23,030.442 100.050 27,357.472
201509 23,677.745 100.110 28,109.535
201512 23,772.753 100.220 28,191.349
201603 23,798.051 100.560 28,125.931
201606 24,290.530 100.790 28,642.461
201609 25,335.652 101.460 29,677.547
201612 26,772.248 101.560 31,329.461
201703 0.000 102.850 0.000
201706 0.000 102.610 0.000
201709 0.000 103.490 0.000
201712 30,359.348 102.990 35,033.874
201803 29,421.072 104.100 33,589.114
201806 30,603.282 104.130 34,928.740
201809 31,691.486 105.650 35,650.357
201812 34,203.609 104.350 38,955.633
201903 32,745.261 104.490 37,244.702
201906 33,662.050 104.880 38,145.092
201909 34,741.282 105.200 39,248.303
201912 37,793.022 105.120 42,728.441
202003 36,561.092 105.540 41,171.136
202006 38,630.842 104.870 43,779.791
202009 41,371.766 106.200 46,298.863
202012 44,072.184 105.765 49,523.546
202103 41,990.643 107.357 46,484.925
202106 43,487.893 107.579 48,043.347
202109 43,596.076 108.759 47,640.047
202112 45,679.858 109.676 49,499.674
202203 43,802.775 111.806 46,561.619
202206 45,513.918 114.083 47,414.899
202209 47,803.709 114.831 49,475.717
202212 51,061.865 115.200 52,678.600
202303 50,343.382 116.550 51,336.042
202306 53,806.428 117.140 54,590.880
202309 57,452.140 119.111 57,325.043
202312 67,306.524 118.848 67,306.524
202403 64,778.533 118.848 64,778.533

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Chong Kun Dang Pharmaceutical  (XKRX:185750) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Chong Kun Dang Pharmaceutical's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=106700.00/41045.6
=2.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Chong Kun Dang Pharmaceutical was 3.13. The lowest was 2.42. And the median was 2.66.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Chong Kun Dang Pharmaceutical Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Pharmaceutical's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Chong Kun Dang Pharmaceutical (XKRX:185750) Business Description

Traded in Other Exchanges
N/A
Address
368 Chungjungro-3Ga, Seodaemun-gu, Seoul, KOR, 120-756
Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).

Chong Kun Dang Pharmaceutical (XKRX:185750) Headlines

No Headlines